Ontology highlight
ABSTRACT: Objectives
Rescreen a large community cohort to examine the progression to heart failure over time and the role of natriuretic peptide testing in screening.Design
Observational longitudinal cohort study.Setting
16 socioeconomically diverse practices in central England.Participants
Participants from the original Echocardiographic Heart of England Screening (ECHOES) study were invited to attend for rescreening.Outcome measures
Prevalence of heart failure at rescreening overall and for each original ECHOES subgroup. Test performance of N Terminal pro-B-type Natriuretic Peptide (NT-proBNP) levels at different thresholds for screening.Results
1618 of 3408 participants underwent screening which represented 47% of survivors and 26% of the original ECHOES cohort. A total of 176 (11%, 95% CI 9.4% to 12.5%) participants were classified as having heart failure at rescreening; 103 had heart failure with reduced ejection fraction (HFREF) and 73 had heart failure with preserved ejection fraction (HFPEF). Sixty-eight out of 1232 (5.5%, 95% CI 4.3% to 6.9%) participants who were recruited from the general population over the age of 45 and did not have heart failure in the original study, had heart failure on rescreening. An NT-proBNP cut-off of 400?pg/mL had sensitivity for a diagnosis of heart failure of 79.5% (95% CI 72.4% to 85.5%) and specificity of 87% (95% CI 85.1% to 88.8%).Conclusions
Rescreening identified new cases of HFREF and HFPEF. Progression to heart failure poses a significant threat over time. The natriuretic peptide cut-off level for ruling out heart failure must be low enough to ensure cases are not missed at screening.
SUBMITTER: Taylor CJ
PROVIDER: S-EPMC4120315 | biostudies-literature | 2014 Jul
REPOSITORIES: biostudies-literature
Taylor Clare J CJ Roalfe Andrea K AK Tait Lynda L Davis Russell C RC Iles Rachel R Derit Marites M Hobbs F D Richard FD
BMJ open 20140711 7
<h4>Objectives</h4>Rescreen a large community cohort to examine the progression to heart failure over time and the role of natriuretic peptide testing in screening.<h4>Design</h4>Observational longitudinal cohort study.<h4>Setting</h4>16 socioeconomically diverse practices in central England.<h4>Participants</h4>Participants from the original Echocardiographic Heart of England Screening (ECHOES) study were invited to attend for rescreening.<h4>Outcome measures</h4>Prevalence of heart failure at ...[more]